When Fear Clouds Judgment- The Psychology Behind The Mysterious Fog Over US And Canada

Updated Jan 10, 2025 | 01:51 PM IST

SummaryA dense, chemical-smelling fog across the US, Canada, and UK triggered panic, respiratory symptoms, and conspiracy theories. Experts attribute it to pollutants trapped by natural fog, amplified by social media fears but is it true?
When Fear Clouds Judgment- The Psychology Behind The Mysterious Fog Over US And Canada

Image Credit: Canva (representational purpose only)

Mysterious Fog in the US , Canada and UK: A dense, eerie fog with a "burning chemical-like smell" has spooked a good part of North America and parts of the United Kingdom and Canada. With social media amplifying all concerns, this phenomenon has sparked attention across all social media platforms. However, at the heart of this mysterious fog are a conjunction of natural events, social psychology, and environmental conditions that culminated in all the conspiracy theories and public health fears. Here's a closer look at the mysterious fog, its potential causes, and the societal response it has triggered.

Fog that Feeds Fear

The first reports of this "mysterious fog" came in from Florida where a resident said that they experienced respiratory symptoms, feverish warmth, and stomach cramps after contact with the fog. Similar stories started flooding social media, and within a day or two, a sinister force seemed to sweep across the United States, Canada, and parts of the UK. From Texas to Minnesota, people reported weird odors and health issues that they thought were linked to this bizarre atmospheric event.

Some witnesses were said to see "white particles" swirling through the air; theories ranged from a chemical attack or experimental weapon to drone-related chemical dispersals and references to historical military experiments, such as the infamous 1950s "Operation Sea-Spray."

Fuel to the fire were added when videos and posts, hundreds of thousands in number, began circulating on social media sites like TikTok and X (formerly Twitter) speculating on the origin of the fog. Hashtags like #ToxicFog went trending for days. Hysteria created a self-reinforcing loop in which every post spurred further scrutiny and fear.

Scientific Explanation of the Dense Mysterious Fog

1. What is Fog?

Fog is essentially a low-lying cloud formed when the air temperature cools to its dew point, causing water vapor to condense into tiny droplets or ice crystals. Several types of fog—advection fog, radiation fog, and valley fog—can form depending on conditions such as warm, moist air moving over cooler land or when temperatures plummet rapidly under clear skies.

2. Why the Chemical Smell?

Such chemical-like smell as reported during the occurrence of fog events is sometimes attributed to air pollution. It acts like a sponge, where it absorbs these pollutants, which include sulfur dioxide and nitrogen oxides, among others, that emit from industries. This mixture, therefore, leads to a stench that could be mistaken as unnatural or even toxic.

Also Read: Health Concerns Rise As US, Canada, and UK Come Under The Blanket Of Thick, Dense, Toxic Fog

3. What are the Health Concerns?

High moisture levels from fog can significantly exacerbate symptoms related to respiration, but especially in already predisposed asthmatics and allergy patients. The connection of these symptoms with actual fever, stomach cramps, and puffy eyes is too remote. Experts assume that the irritating effects of entrapped pollutants trapped in fog tend to affect more the eyes and throat rather than the rest of the body affected by some report.

Psychological Effects of Mass Panic Caused by Social Media

Social media amplified a natural weather event into a health epidemic. It made the personal experience of individuals become a cause for fear and speculation, a domino effect.

According to psychologists, this is a concept of selective perception, wherein once people's attention is drawn to environmental anomalies, they begin to notice them. This mirrors earlier panics, such as the Seattle windshield pitting panic of 1954. Then, atomic bomb testing caused fear in many and started to have people looking at their windshields for small marks that they had not seen before. Likewise, postings on the strangeness of the fog probably increased public awareness and suspicion, with people looking to attach unrelated symptoms to the phenomenon.

The fog hysteria shares a commonality with other instances of mass panic, such as the "drone sightings" of recent years or the Cold War-era fears of biological warfare.

Also Read: Mysterious Fog Is Making Americans Sick

These events underscore how fear can cloud judgment, especially when amplified by social media and sensationalist headlines. While historical cases, such as "Operation Sea-Spray," offer concrete evidence of the existence of unethical experiments, the jump from a natural weather condition to theories of chemical attacks exemplifies a more modern trend of connecting unrelated dots, all wonderfully seeded in distrust and anxiety.

Despite the swirling rumors, meteorologists and scientists are in agreement that the mysterious fog is not as alarming as it seems. It is well known that fog traps and amplifies pollutants, especially in urban and industrial regions. Moreover, winter months are the most conducive for fog formation, so its recent prevalence is unsurprising.

On the other hand, environmentalists advise that the fog should wake everyone up to increased levels of pollution. The reported odors and health irritations could be just symptoms of far deeper systemic issues like industrial emissions and lack of control over air quality.

The authorities must be transparent in their communication to combat misinformation and allay public fears. Governments and environmental agencies must provide timely updates on weather phenomena, air quality, and health risks. Initiatives like real-time pollutant tracking and public education campaigns can help demystify natural occurrences while addressing valid environmental concerns.

The mysterious Canada fog is a compelling case study in how environmental events intersect with psychology and societal dynamics. While rooted in natural phenomena, the fog became a vessel for collective fears, amplified by modern technology and historical anxieties.

In this information era where communication occurs at an almost lightning pace, the fog becomes a metaphor that reminds everyone about scientific literacy, environmental responsibility, and an effective balance when considering public concern. Whether perceived as a marvel of nature or as a tale that serves to teach, it left a very powerful mark in people's minds.

End of Article

Eli Lilly Moves Beyond GLP-1 Drugs, To Spend 2.88 Billion On Autoimmune Drug Development

Updated Sep 1, 2026 | 06:07 AM IST

SummaryEli Lilly is set to acquire privately-held biotech company Merida Biosciences for up to $2.875 billion in its big move for a big autoimmune drug push.
Eli Lilly Moves Beyond GLP-1 Drugs, To Spend $2.88 Billion On Autoimmune Drug Development

Credit: AI

Eli Lilly has made its latest move to look beyond the blockbuster GLP-1 market by agreeing to acquire biotech company Merida Biosciences for up to $2.875 billion in cash.

The deal will give Lilly access to Merida's experimental treatments for autoimmune and allergic diseases, including a potential drug for Graves' disease and thyroid eye disease. The transaction is expected to be completed in the fourth quarter of 2026, subject to regulatory approvals and other conditions.

The acquisition is another sign that Lilly is trying to diversify its pipeline beyond the obesity and diabetes medicines that have driven its recent growth. Lilly's spending on similar deals in 2026 that signals the company is looking to to expand beyond its successful hold on GLP-1 markets.

From Weight Loss Medications To Autoimmune Disease Drugs

Merida's lead programme, MER511, is currently in Phase 1 development for Graves' disease and thyroid eye disease (TED). The experimental treatment uses Merida's antibody-engineering platform to selectively remove pathogenic autoantibodies, the antibodies responsible for driving certain autoimmune diseases.

The idea is different from conventional immune-suppressing medicines, which dampen immune activity broadly. Initial Phase 1 data showed that MER511 substantially reduced thyroid-stimulating antibodies associated with Graves' disease and TED, while showing a favourable initial safety profile.

Francisco Ramírez-Valle, Lilly's senior vice president of immunology research and early clinical development, said, “We're building our pipeline around therapies that meaningfully change the course of disease, not just its downstream effects.”

He added that Merida's lead programme is designed to selectively and directly target the antibodies driving Graves' disease and thyroid eye disease.

Also read: Eli Lilly’s Foundayo Launched In UK: Is the GLP-1 Pill Better Than Wegovy, Mounjaro?

Different Drug Approach To Autoimmune Disease

In thyroid eye disease, inflammation can cause eye bulging, pain, double vision and, in severe cases, vision impairment.

Lilly's interest is specifically in Merida's approach is its attempt to target the disease-causing antibodies themselves, rather than suppressing the immune system more broadly.

Merida CEO Adam Townsend said, “Merida was founded to fundamentally change how autoimmune and allergic diseases are treated, by targeting the antibodies driving them directly, rather than suppressing the immune system broadly.”

That could potentially offer a more precise way of treating diseases in which specific autoantibodies are driving the damage.

Also read: Wegovy Is The Go-To Weightloss Drug Choice For Most US Teens

Lilly's Expanding Pipeline

The acquisition isn't only about Graves' disease. Merida's pipeline includes MER769, an experimental programme being developed for food allergy, asthma, chronic spontaneous urticaria and other allergic diseases.

The company also has earlier-stage programmes targeting kidney diseases and other conditions mediated by immunity.

This gives Lilly a potential base across a much broader range of immune-mediated diseases. The company that became synonymous with Mounjaro and Zepbound is trying to build a pharmaceutical portfolio that does not cash in entirely on the GLP-1 boom.

MER511 is still only in Phase 1, meaning its safety and preliminary biological activity are being evaluated in early clinical testing. The promising initial data do not yet establish whether the drug will ultimately work in larger patient populations or receive regulatory approval.

The $2.88-billion deal is therefore not Lilly buying an already-proven autoimmune medicine. It is buying a platform and the potential for an entirely new class of treatments.

As Townsend put it, “Joining Lilly gives our science the resources and commitment to realize its potential for patients with immune-mediated conditions.”

End of Article

Pharmacies In England To Launch Free 7-Minute Cholesterol Checks: Why Is It Important?

Updated Aug 31, 2026 | 11:00 PM IST

SummaryPeople aged 40 to 84 who are not pregnant and have not had a blood test in the past year will be eligible to walk in and get tested. Eligible people will also be offered a blood pressure check as part of a clinical consultation with a pharmacist prescriber.
Pharmacies in England to Launch Free 7-Minute Cholesterol Checks: Why Is It Important?

Credit: iStock

The NHS in England today announced that 100 pharmacies will offer free cholesterol check-ups beginning this autumn.

The initiative is part of an NHS drive to reduce heart disease and stroke deaths by a quarter over the next decade. It will include free finger-prick blood tests for cholesterol on the high street for the first time.

Who Is Eligible?

People aged 40 to 84 who are not pregnant and have not had a blood test in the past year will be eligible to walk in and get tested.

Eligible people will also be offered a blood pressure check as part of a clinical consultation with a pharmacist prescriber.

The NHS pilot will run until spring 2027.

How Will The Test Be Conducted?

Blood will be taken from a person’s fingertip using a lancet — a small, sharp medical tool used to prick the skin — and analyzed immediately. A pharmacist prescriber can then provide lifestyle advice and determine whether any treatment, such as statins, may be needed.

Patients will receive a copy of their results by email. They will also be offered a blood pressure check as part of a clinical consultation with a pharmacist prescriber.

How Will It Help?

The national rollout follows a successful smaller pilot in north London, which tested 2,493 patients at 61 community pharmacies between January 2025 and March 2026.

Nearly one in five patients were found to be suitable for pharmacological intervention, and 88 people started taking statins.

David Webb, the chief pharmaceutical officer for England, said pharmacies could be a vital first line of defense against serious illness.

He said: “By making it easier for people to get a quick and convenient cholesterol health check on their local high street, we can spot ticking timebombs earlier, helping people take action, and prevent heart attacks and strokes before they happen.

“This is the latest in a series of initiatives involving pharmacies in delivering care previously only offered in GP surgeries as part of the 10-year health plan to bring care closer to where people live.”

Will This Be Scaled Up?

In the first phase of the national rollout, about 100 NHS pharmacies across England will begin offering the checks from this autumn.

Dr Rani Khatib, NHS England’s national specialty adviser for cardiovascular disease prevention, said everyone should strive to be aware of the most common risk factors for heart disease, including high cholesterol and blood pressure, and “know their numbers”.

“This initiative will help people manage their risk factors earlier and reduce their risk of having heart attacks or strokes,” he said.

Alison McGovern, a health minister, said it was “exactly the type of innovation” she wanted to see across the NHS.

“We’re making it easier for people to spot potential problems earlier and take action to protect their health,” she said.

“Early detection can help prevent serious conditions such as heart attacks and strokes, helping people stay healthier for longer while reducing pressure on NHS services.”

How Does High Cholesterol Raise Heart Risks?

Too much LDL (“bad”) cholesterol in the blood can build up inside artery walls. Over time, these fatty deposits — called plaque or atheroma — can make arteries narrower and restrict blood flow, according to the NHS.

High cholesterol usually causes no symptoms, which is why testing is important. Cholesterol can be reduced through healthier eating and regular exercise and, for people at sufficient risk, medicines such as statins.

End of Article

Measles In US: 3 More States Report Significant Uptick In Cases; How To Spot Initial Symptoms?

Updated Sep 1, 2026 | 12:00 AM IST

SummaryThe states include Pennsylvania, Wisconsin, and Georgia. Pennsylvania has also reported two deaths, including an Amish newborn, marking 2026’s first measles-related deaths in the country.
Measles In US: 3 States Report Significant Uptick In Cases; How To Spot Initial Symptoms?

Credit: iStock

Amid declining childhood vaccination rates and an anti-vaccine push from the government, the US is reporting a significant uptick in measles cases in three more states.

The states include Pennsylvania, Wisconsin, and Georgia. Pennsylvania has also reported two deaths, including an Amish newborn, marking 2026’s first measles-related deaths in the country.

  • Pennsylvania
The state reported 460 confirmed cases as of late August 2026, with Lancaster County serving as the epicenter, with 210 cases.

Two unvaccinated individuals, including a newborn infant, died, marking the first measles-associated deaths in the state in 35 years.

  • Wisconsin
Wisconsin is experiencing its largest measles outbreak in decades. The Wisconsin Department of Health Services reported a significant increase in measles cases associated with the outbreak in Grant, Iowa and Lafayette counties, rising from 42 reported on Tuesday to 92 reported on Friday.

  • Georgia
Health officials are managing a cluster tied to a metro Atlanta daycare. The Georgia Department of Public Health confirmed four new measles cases in late August 2026, bringing the state’s total number of cases to 14 for the year.

Also read: Measles: Infant Among Two Unvaccinated Deaths Reported In US

Measles Cases Surging In The US

According to the Centers for Disease Control and Prevention, 2,903 confirmed cases had been reported nationwide as of August 27, threatening the US measles-elimination status held since 2000.

About 94% of cases are among unvaccinated people, and children under 5 account for 19% of cases.

This is the highest number of cases reported since the major resurgence between 1989 and 1991, when 55,000 infections and 123 deaths were recorded.

In comparison, for the full year 2025, the country reported 2,289 cases and three deaths.

While two doses of the MMR vaccine are key to preventing measles, the highly contagious virus, the first MMR dose is recommended at 12 to 15 months, followed by a second dose at 4 to 6 years.

The anti-vaccine stance promoted by the Trump-led US government and HHS Secretary RFK Jr. comes as cases are spiraling. More recently, Trump also announced a split of the MMR vaccine.

What Is the First Sign of Measles Infection?

Measles is a serious and highly contagious illness that can be particularly dangerous for babies and young children. The best way to prevent measles is to get vaccinated.

The measles, mumps and rubella (MMR) vaccine is a safe and effective way to protect yourself and others from this dangerous disease.

Measles is more than just a simple rash and can lead to severe health problems and, in some cases, death.

The first signs of measles often mimic a common cold. These initial symptoms include a high fever that can reach over 104°F, a persistent cough, a runny nose, and red, watery eyes.

These symptoms can be misleading, but their combination is a key indicator of the onset of measles.

A distinctive sign of measles is the appearance of tiny white spots, called Koplik spots, inside the mouth. These spots typically develop two to three days after the initial symptoms begin.

Their presence is an important diagnostic clue, often appearing before the characteristic measles rash.

What Does a Measles Rash Look Like?

A rash appears three to five days after the initial symptoms. It usually starts as flat red spots on the face, near the hairline, and then spreads downward to the neck, trunk, arms, legs and feet.

The spots can sometimes be slightly raised and may merge. When the rash appears, the fever may also increase significantly.

Who Is Most at Risk?

While measles can be serious for anyone, certain groups are at a higher risk of developing complications. These include:

  • Children younger than 5 years old
  • Adults older than 20 years old
  • Pregnant women
  • People with weakened immune systems due to conditions like leukemia or HIV

End of Article